ARTICLE | Clinical News
Cysteamine bitartrate regulatory update
April 28, 2014 7:00 AM UTC
The European Commission granted Orphan Drug designation to Raptor's RP103 to treat pancreatic cancer. The product is approved as Procysbi in the EU and U.S. to treat nephropathic cystinosis, for which...